B+
Bull case
25%
Probability
Target price
$51.74
Analysis reference price unavailable
Analysis 2025-11-29 · RankAlpha Sentiment AI
MBX
MBX BiosciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive clinical or regulatory outcomes plus a partnership/licensing deal would re-rate the stock; partnership proceeds and reduced dilution support the >50% upside implied by the bull target.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Clinical setbacks, missed guidance, or dilutive financing would likely trigger sharp declines, consistent with the >30% downside implied by the bear target.
Momentum
73
Value
41
Sentiment
16
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $37.94 · Bull $51.74 · Bear $24.14Analysis 2025-11-29; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-29 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $88.36
Why
Momentum73 · Δ7d -21.9
Value41 · Δ7d -0.0
Sentiment16 · Δ7d -0.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Clinical setbacks, missed guidance, or dilutive financing would likely trigger sharp declines, consistent with the >30% downside implied by the bear target.
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Clinical/regulatory readout or milestone
Lead driver: Value · See fundamentals
Momentum
73
9% active weight
Current posture
7d trendSoftening
Δ7d
-21.9
Δ21d
-28.9
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-5.2
Sentiment
16
62% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
+7.8
Why this grade
Composite grade F. Momentum 72.8 / Value 41.2 / Sentiment 16.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-11-29. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$37.94
Analysis reference price unavailable
Analysis 2025-11-29 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$24.14
Analysis reference price unavailable
Analysis 2025-11-29 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$3.29B
Beta
-
Shares Out
48.16M
P/E (TTM) · Derived
-28.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-34.07
Rev YoY
-
EPS YoY
+34.0%
Gross Margin
-
Op Margin
-
Net Debt
-$373.11M
Current Ratio
18.08
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data